Elan Gets FDA OK for Prialt Painkiller
14679
Biotech company Elan Corp. reported Tuesday that the Food and Drug Administration approved its non-narcotic painkiller Prialt to treat chronic pain.
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.
381456
Eli Lilly & Co  and Japan's  Daiichi Sankyo Co Ltd (4568.T) said on Friday they had asked  U.S. regulators to approve prasugrel, a blood clot preventer  that is the U.S. drug maker's most important experimental  product.
480434
Shares of Elan Corp., Ireland&#39;s biggest drugmaker, rose as much as 7.7 percent after a newspaper reported that the company&#39;s US partner Biogen Idec Inc.
205700
Elan shares jumped this morning after it said that US regulators had approved it new once-a-month multiple sclerosis drug. Tysabri, developed by Elan and Biogen and formerly called Antegren, is the first kind
708813
An FDA advisory panel votes favorably on Adolor's lead drug.
718942
Cadila Healthcare Ltd said on Tuesday it received approval from U.S. health regulators for its hydroxychloroquine sulphate tablets.
514348
Pfizer Inc. won U.S. approval on Friday to promote its Celebrex pain reliever for treating children age two and older who have rheumatoid arthritis, the Food and Drug Administration said on Friday.
226304
The announcement comes on the eve of a three-day FDA meeting called to discuss the safety of painkillers like Merck &#38; Co.
753742
QLT Inc. (QLT.TO: Quote, Profile, Research) (QLTI.O: Quote, Profile, Research) said on Wednesday it won US regulatory approval for the six-month formulation of its prostate cancer treatment, Eligard.
20582
WASHINGTON : A skin patch providing sexual stimulation for menopausal women that promises to do what Viagra did for men will begin its approval procedure on Thursday at the Federal Drug Administration (FDA).
133355
Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.
731856
British regulators recommended that physicians restrict the use of the anti-depressant Efexor because its use could have side effects for heart health and pose other risks that require more careful monitoring than its competitors. The drug's manufacturer, Wyeth, said it would challenge the decision, but its shares slipped 3 percent.
753540
The first implantable treatment to prevent sleep apnea has received approval from U.S. regulators, the company that developed the procedure said Tuesday.
754376
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
15252
GlaxoSmithKline Plc, Europe's biggest  drugmaker, said on Monday a U.S. court had ruled in its favor  in patent litigation with Israel's Teva Pharmaceuticals over  anti-nausea drug Zofran.
556783
QLT Inc. QLT.TO QLTI.O said on  Wednesday it won U.S. regulatory approval for the six-month  formulation of its prostate cancer treatment, Eligard.